Technical Analysis for INZY - Inozyme Pharma, Inc.

Grade Last Price % Change Price Change
B 6.00 1.87% 0.11
INZY closed up 1.87 percent on Monday, March 18, 2024, on 1.43 times normal volume.
Earnings due: Mar 20
*** please verify all earnings dates ***
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Oversold Stochastic Weakness 0.00%
Pocket Pivot Bullish Swing Setup 1.87%
Oversold Stochastic Weakness 1.87%
Outside Day Range Expansion 6.76%
Oversold Stochastic Weakness 6.76%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 3.99%
Stochastic Reached Oversold Weakness 3.99%
Inside Day Range Contraction 3.99%
Oversold Stochastic Weakness 3.99%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 10 hours ago
Up 5% about 14 hours ago
Rose Above 20 DMA about 15 hours ago
Up 3% about 15 hours ago
Up 2% about 15 hours ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inozyme Pharma, Inc., a rare disease biopharmaceutical company, engages in developing therapeutics for treating abnormal mineralization impacting the vasculature, soft tissue, and skeleton diseases. The company's lead product candidate is INZ-701, a soluble, recombinant protein to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies, as well as in the early stages of development for calciphylaxis. It has a license agreement with Yale University for specified therapeutic and prophylactic products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Disease Pharmacy Molecular Biology Specialty Drugs Genetic Diseases Rare Genetic Disease Rare Genetic Diseases Recombinant Dna

Is INZY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 7.33
52 Week Low 2.689
Average Volume 488,974
200-Day Moving Average 4.75
50-Day Moving Average 5.41
20-Day Moving Average 6.05
10-Day Moving Average 5.96
Average True Range 0.39
RSI (14) 53.49
ADX 23.72
+DI 25.05
-DI 19.69
Chandelier Exit (Long, 3 ATRs) 5.85
Chandelier Exit (Short, 3 ATRs) 6.61
Upper Bollinger Bands 6.76
Lower Bollinger Band 5.33
Percent B (%b) 0.47
BandWidth 23.58
MACD Line 0.11
MACD Signal Line 0.20
MACD Histogram -0.0888
Fundamentals Value
Market Cap 370.56 Million
Num Shares 61.8 Million
EPS -1.44
Price-to-Earnings (P/E) Ratio -4.17
Price-to-Sales 0.00
Price-to-Book 2.24
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.70
Resistance 3 (R3) 6.70 6.47 6.58
Resistance 2 (R2) 6.47 6.29 6.47 6.54
Resistance 1 (R1) 6.24 6.18 6.35 6.23 6.50
Pivot Point 6.01 6.01 6.06 6.00 6.01
Support 1 (S1) 5.77 5.83 5.89 5.77 5.50
Support 2 (S2) 5.54 5.72 5.54 5.46
Support 3 (S3) 5.31 5.54 5.42
Support 4 (S4) 5.30